Literature DB >> 1712768

Dynamics of differentiation in human epidermoid squamous carcinoma cells (A431) with continuous, long-term gamma-IFN treatment.

J Ridge1, J Muller, P Noguchi, E H Chang.   

Abstract

We investigated the long-term effects of continuous gamma interferon (gamma-IFN) treatment on A431, a human squamous carcinoma cell line. Cells were grown in an in vitro culture system, which over time produces cohesive cell masses ("tumoroids") exhibiting three-dimensional, histotypically differentiated structures, e.g., keratin "pearls", intercellular bridges (desmosomes), elongated flattened cells (squames) and stratification. The effects of gamma-IFN on cell growth, morphology and stage of differentiation were assessed at different treatment times by light and electron microscopy and by immunohistochemical staining using antibodies to keratins 1 and 14 and to filaggrin, markers of specific stages of keratinocyte differentiation. Our results show that A431 cells have the capacity for spontaneous differentiation, that this capacity is significantly enhanced and accelerated by gamma-IFN treatment leading to terminal differentiation and extensive cell death by 2 wk. Despite continuous exposure to IFN, a small number of viable, undifferentiated cells remain. Their proliferation, evident by 3 wk, reconstitutes the tumoroid which once again contains the full range of differentiating cell types.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712768     DOI: 10.1007/bf02630962

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  25 in total

1.  The use of cDNA clones and monospecific antibodies as probes to monitor keratin gene expression.

Authors:  D R Roop; C K Cheng; R Toftgard; J R Stanley; P M Steinert; S H Yuspa
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Effects of human recombinant interferons-alpha 2, -beta and -gamma on growth and survival of human cancer nodules maintained in continuous organotypic culture.

Authors:  R Beaupain; C Billard; E Falcoff
Journal:  Eur J Cancer Clin Oncol       Date:  1986-02

Review 3.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Interferons in the treatment of human cancer.

Authors:  J M Kirkwood; M S Ernstoff
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

Review 5.  Effects of interferon on differentiation of normal and tumor cells.

Authors:  P B Fisher; S Grant
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

6.  Modulation of involucrin and envelope competence in human keratinocytes by hydrocortisone, retinyl acetate, and growth arrest.

Authors:  P R Cline; R H Rice
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

7.  Interferon-gamma induces altered oncogene expression and terminal differentiation in A431 cells.

Authors:  E H Chang; J Ridge; R Black; Z Q Zou; T Masnyk; P Noguchi; J B Harford
Journal:  Proc Soc Exp Biol Med       Date:  1987-12

Review 8.  Interferon review.

Authors:  G J Stanton; D A Weigent; W R Fleischmann; F Dianzani; S Baron
Journal:  Invest Radiol       Date:  1987-03       Impact factor: 6.016

9.  Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation.

Authors:  D Resnitzky; A Yarden; D Zipori; A Kimchi
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

10.  Regulation of human mesothelial cell differentiation: opposing roles of retinoids and epidermal growth factor in the expression of intermediate filament proteins.

Authors:  K H Kim; V Stellmach; J Javors; E Fuchs
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  3 in total

1.  Differences of reactivity to interferon gamma in HeLa and CaSki cells: a combined immunocytochemical and flow-cytometric study.

Authors:  G Lizard; M C Chignol; Y Chardonnet; D Schmitt
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis.

Authors:  Eva Pericolini; Elena Gabrielli; Nathalie Ballet; Samuele Sabbatini; Elena Roselletti; Amélie Cayzeele Decherf; Fanny Pélerin; Eugenio Luciano; Stefano Perito; Peter Jüsten; Anna Vecchiarelli
Journal:  Virulence       Date:  2016-07-19       Impact factor: 5.882

3.  In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans.

Authors:  Elena Gabrielli; Samuele Sabbatini; Elena Roselletti; Lydia Kasper; Stefano Perito; Bernhard Hube; Antonio Cassone; Anna Vecchiarelli; Eva Pericolini
Journal:  Virulence       Date:  2016-04-29       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.